ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Celera Corp. (MM)

Celera Corp. (MM) (CRA)

8.04
0.00
( 0.00% )
Updated: 20:00:00

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

CRA News

Official News Only

CRA Discussion

View Posts
UserAlias1 UserAlias1 9 years ago
.
👍️0
datakid datakid 13 years ago
CRA: BVF bought more CRA stock recently www.prontosec.com/secdata/dailyReport.htm, why pay price higher than sale price of $8 paid by DGX?
👍️0
conix conix 13 years ago
CRA Short Interest

Short Interest (Shares Short)
3,757,700
👍️0
conix conix 13 years ago
CRA hits the list of option traders/speculators expecting a rebound

Celera Corporation (CRA)Market cap of $474.72M.

Call open interest at 1,392 contracts vs. put open interest at 171 contracts (Put/Call ratio at 0.12).

Short float at 5.23% of public float.
👍️0
surf1944 surf1944 14 years ago
7:01AM Celera Genomics publishes data extending the association between the KIF6 gene variant and differential reduction of coronary events from statin therapy to the elderly with prior vascular disease (CRA) 6.98 : Co announces the publication of data reporting that elderly carriers of the KIF6 gene variant with prior vascular disease received significant benefit from pravastatin therapy. Previous research has shown that a variant of the KIF6 gene, a member of the molecular motor protein kinesin family, is associated with up to a 55% increased risk of primary and recurrent coronary heart disease events in the placebo arms of the clinical trials, and that this increased risk is virtually eliminated with statin therapy. The effect of pravastatin versus placebo on coronary events according to KIF6 carrier status was investigated among 5,752 patients of the PROspective Study of Pravastatin in the Elderly at Risk study.
👍️0

Your Recent History

Delayed Upgrade Clock